“We are currently used as guinea pigs. We don’t know the long term effects. We don’t know where we’re going to see each other in the future with this shot we’ve already received, ”said parent Alan Radtke.
READ MORE: Firefighters are busy across the region as conditions warning of red flag fuel fires
“Our children are too young. It is too recent a plan. I will not do it. As an adult our immune system is much stronger, ”said parent Mai Xiong.
Parent Alan Taylor is a little more open to the idea saying, “Anything to get us as close to normal as possible.”
UC Davis Health hopes 100 children will register to participate. The trial uses the Novavax vaccine. Children give a blood sample and are then monitored for 30 minutes after receiving their first injection. They then return three weeks later for the second shot.
READ MORE: CHP issues endangered disappearance advisory for 11-year-old girl, last seen in Arden area
“The most vulnerable are those who are not vaccinated, so that includes children,” said Dr. Dean Blumberg.
The chief of pediatric infectious diseases at UC Davis Children’s Hospital, Dr. Dean Blumberg, will lead the pediatric portion of the study.
Dr Blumberg says children now account for more than 20% of cases. While adults have been hit the hardest by the virus, Dr Blumberg points out that thousands of children have been hospitalized and hundreds have died from COVID. Dr Blumberg says if parents can be hesitant about a childhood vaccine, the trial is essential.
“All the studies carried out so far with the COVID vaccine have found an excellent immune response in the younger age groups compared to the older groups and have very similar safety profiles in the younger age group by compared to the older group.
NO MORE NEWS: Man in critical condition after being shot near South Sacramento Park
Neither the participants nor the researchers will know whether they are receiving the vaccine or a placebo. Participants will receive compensation. To register, visit the study’s website.